Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angle Bio Pharma (Beijing Angle Bio-Pharma Co., Ltd.) is a leading Chinese Contract Research Organization (CRO) that provides comprehensive clinical development and regulatory services to the global pharmaceutical and medical device industries. Founded in 2003 and headquartered in Beijing, the company specializes in Phase I-IV clinical trial management, site management (SMO), data management, and biostatistics. It serves as a critical strategic partner for international sponsors seeking to navigate the complex National Medical Products Administration (NMPA) regulatory landscape to enter the Chinese market. With a robust infrastructure spanning over 30 cities in China, Angle Bio Pharma supports a wide range of therapeutic areas, with particular expertise in oncology, cardiology, and metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ANGLE Bio Pharma.